Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy
Clinical trial NCT00464776 · COMPLETED
Trial details
- NCT number
- NCT00464776
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2008-04-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.